CASI Pharmaceuticals Operating Cycle Over Time
| CASI Stock | USD 0.96 0.08 7.69% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CASI Pharmaceuticals Performance and CASI Pharmaceuticals Correlation. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CASI Pharmaceuticals. If investors know CASI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CASI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.02) | Revenue Per Share | Quarterly Revenue Growth (0.60) | Return On Assets | Return On Equity |
The market value of CASI Pharmaceuticals is measured differently than its book value, which is the value of CASI that is recorded on the company's balance sheet. Investors also form their own opinion of CASI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is CASI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CASI Pharmaceuticals' market value can be influenced by many factors that don't directly affect CASI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CASI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if CASI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CASI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Cycle Analysis
Compare CASI Pharmaceuticals and related stocks such as Clearside Biomedical, Cingulate, and Entero Therapeutics Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CING | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 58.8813 | 52.99 | 47.1 |
| CRIS | 6.8521 | 1.0401 | (788) | (878) | (454) | (986) | (1 K) | 113 | (436) | 118 | 103 | 111 | 107 | 102 | 112 | 129 | 135 |
| PTHS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| NCNA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PALI | 2.9839 | 2.9839 | 2.9839 | 33.1818 | 4.4 K | 1.3 K | 1.4 K | 522 | 503 | 499 | 216 | 216 | 216 | 216 | 216 | 248 | 236 |
| ALLR | 93.5685 | 93.5685 | 93.5685 | 93.5685 | 93.5685 | 93.5685 | 5.8736 | 130 | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 4.5 K | 4.8 K |
| KAPA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| LSTA | 2.1675 | 64.0409 | 60.8354 | 82.112 | 123 | 94.3703 | 2.9 K | 4.9 K | 328 | 328 | 328 | 328 | 328 | 328 | 328 | 296 | 281 |
CASI Pharmaceuticals and related stocks such as Clearside Biomedical, Cingulate, and Entero Therapeutics Operating Cycle description
My Equities
My Current Equities and Potential Positions
| CASI Pharmaceuticals | CASI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 1701-1702, China Central |
| Exchange | NASDAQ Exchange |
USD 0.96
Check out CASI Pharmaceuticals Performance and CASI Pharmaceuticals Correlation. For more detail on how to invest in CASI Stock please use our How to Invest in CASI Pharmaceuticals guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
CASI Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.